Angiogenesis and angiogenesis inhibitors in paediatric diseases
- 1 July 1992
- journal article
- review article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 151 (7) , 472-476
- https://doi.org/10.1007/bf01957746
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Diffuse infantile haemangiomatosis: clinicopathological features and management problems in five fatal casesEuropean Journal of Pediatrics, 1991
- The structure and function of the int-2 oncogeneProgress in Growth Factor Research, 1989
- A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: Purification and N-terminal amino acid sequenceBiochemical and Biophysical Research Communications, 1989
- Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low‐dose methotrexateArthritis & Rheumatism, 1989
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Differential expression of two homologous and clustered oncogenes, Hst1 and Int-2, during differentiation of F9 cellsBiochemical and Biophysical Research Communications, 1988
- Basic fibroblast growth factor and its relation to angiogenesis in normal and neoplastic tissueJournal of Molecular Medicine, 1988
- Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells.Journal of Clinical Investigation, 1987
- Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cellsBiochemical and Biophysical Research Communications, 1987
- Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growthNature, 1987